Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial
Sponsor: Washington University School of Medicine
Summary
This protocol describes a feasibility trial that will evaluate the feasibility of conducting a full-scale phase 3 trial testing the hypothesis that a postoperative sustained, low-dose ketamine infusion can prevent postoperative depressive symptoms when administered to a targeted population of neurosurgical patients with a history of depression.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
32
Start Date
2022-04-25
Completion Date
2023-03-08
Last Updated
2026-08-21
Healthy Volunteers
No
Conditions
Interventions
Ketamine
NMDA antagonist
Normal saline
IV fluid acting as a placebo
Locations (1)
Washington University School of Medicine
St Louis, Missouri, United States